Basaloid squamous carcinoma (BSC) is a rare distinct variant of squamous cell carcinoma of the head and neck region. This entity may commonly pose diagnostic difficulties, especially on small biopsy material. We report the clinicopathological characteristics of 12 new cases and compare their immunohistochemical features with those of solid adenoid cystic carcinomas and conventional squamous cell carcinomas. Our results show that neoplastic BSCs and squamous cell carcinomas do not react to vimentin and S100 protein, while adenoid cystic carcinomas manifest both. The BSCs, however, are S100 protein-positive in intratumoral dendritic Langerhans' cells that are lacking in squamous cell and adenoid cystic carcinomas. Our findings indicate that the immunohistochemical differences between BSC and adenoid cystic carcinoma could assist in their differential diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archotol.1993.01880200093013DOI Listing

Publication Analysis

Top Keywords

adenoid cystic
20
squamous cell
20
cystic carcinomas
12
basaloid squamous
8
squamous carcinoma
8
carcinoma head
8
head neck
8
cystic carcinoma
8
cell carcinoma
8
cell carcinomas
8

Similar Publications

Purpose: Boron neutron capture therapy (BNCT) perform as a treatment option for locally advanced or recurrent unresectable head and neck cancers since June 2020 in Japan. The effect of BNCT on parotid carcinoma, which presents a variety of histologic types, remains unclear. The object of this study was to investigate the antitumor efficacy of BNCT against parotid gland carcinoma by focusing on LAT1, which is involved in the uptake of L-BPA, the boron compound used in BNCT.

View Article and Find Full Text PDF

Introduction: Salivary gland malignancies are heterogeneous tumors with highly variable outcomes. Elective neck management options include observation, neck dissection (ND), and neck irradiation (NI). We sought to compare outcomes of cN0 salivary gland cancer by elective neck management.

View Article and Find Full Text PDF

Adenoid cystic carcinoma (ACC) of the breast is an exceptionally rare malignancy, accounting for less than 0.1% of all breast cancers. Despite its favorable prognosis, optimal management remains undefined due to its rarity and lack of consensus guidelines.

View Article and Find Full Text PDF

Background: Primary pulmonary and bronchial adenoid cystic carcinoma (PACC) is a rare, low-grade malignant tumor of the lung. However, the relationship between its clinical features, surgical prognosis, and genetic phenotype has not been fully described.

Methods: PACC patient information was collected from the SEER, TCGA, and Zhongshan Hospital, Fudan University (FDZSH) databases.

View Article and Find Full Text PDF

Tracheobronchial adenoid cystic carcinoma in pregnancy.

BMJ Case Rep

January 2025

Department of Endocrinology and Obstetric Medicine, Queensland Health, Brisbane, Queensland, Australia

A case of tracheobronchial adenoid cystic carcinoma diagnosed around the time of conception and its progression during pregnancy is presented. The evidence that pregnancy may be associated with the progression of adenoid cystic cancer is discussed. It is important to consider tracheal disease before making a diagnosis of adult-onset asthma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!